New nanomedicine could prevent progression of pancreatic cancer
A new study published in scientific journal Nature Communications distinguishes the reason for extended pancreatic cancer survival: an inverse correlation between a known oncogene, a gene that promotes the development of cancer, and the expression of an oncosuppressor microRNA.
The study may serve as a basis for the development of a medicine that...